Refine
Document Type
- Article (4)
- Doctoral Thesis (1)
Language
- English (5)
Has Fulltext
- yes (5)
Is part of the Bibliography
- no (5)
Keywords
- - (3)
- Individualization (2)
- microbiome (2)
- Epidemiologie (1)
- Metabolomics (1)
- NMR metabolomics (1)
- Statistik (1)
- Urine diagnostics (1)
- alpha diversity (1)
- bacterial community (1)
Institute
- Klinik für Psychiatrie und Psychotherapie (5) (remove)
Publisher
- MDPI (3)
- SAGE Publications (1)
Microbial metabolites measured using NMR may serve as markers for physiological or pathological host–microbe interactions and possibly mediate the beneficial effects of microbiome diversity. Yet, comprehensive analyses of gut microbiome data and the urine NMR metabolome from large general population cohorts are missing. Here, we report the associations between gut microbiota abundances or metrics of alpha diversity, quantified from stool samples using 16S rRNA gene sequencing, with targeted urine NMR metabolites measures from 951 participants of the Study of Health in Pomerania (SHIP). We detected significant genus–metabolite associations for hippurate, succinate, indoxyl sulfate, and formate. Moreover, while replicating the previously reported association between hippurate and measures of alpha diversity, we identified formate and 4-hydroxyphenylacetate as novel markers of gut microbiome alpha diversity. Next, we predicted the urinary concentrations of each metabolite using genus abundances via an elastic net regression methodology. We found profound associations of the microbiome-based hippurate prediction score with markers of liver injury, inflammation, and metabolic health. Moreover, the microbiome-based prediction score for hippurate completely mediated the clinical association pattern of microbial diversity, hinting at a role of benzoate metabolism underlying the positive associations between high alpha diversity and healthy states. In conclusion, large-scale NMR urine metabolomics delivered novel insights into metabolic host–microbiome interactions, identifying pathways of benzoate metabolism as relevant candidates mediating the beneficial health effects of high microbial alpha diversity.
For the goal of individualized medicine, it is critical to have clinical phenotypes at hand which represent the individual pathophysiology. However, for most of the utilized phenotypes, two individuals with the same phenotype assignment may differ strongly in their underlying biological traits. In this paper, we propose a definition for individualization and a corresponding statistical operationalization, delivering thereby a statistical framework in which the usefulness of a variable in the meaningful differentiation of individuals with the same phenotype can be assessed. Based on this framework, we develop a statistical workflow to derive individualized phenotypes, demonstrating that under specific statistical constraints the prediction error of prediction scores contains information about hidden biological traits not represented in the modeled phenotype of interest, allowing thereby internal differentiation of individuals with the same assigned phenotypic manifestation. We applied our procedure to data of the population-based Study of Health in Pomerania to construct a refined definition of obesity, demonstrating the utility of the definition in prospective survival analyses. Summarizing, we propose a framework for the individualization of phenotypes aiding personalized medicine by shifting the focus in the assessment of prediction models from the model fit to the informational content of the prediction error.
Aiming at the goal of individualized medicine, this dissertation develops a generic methodology to individualize risk factors and phenotypes via metabolomic data from the urine. As metabolomic data can be seen as a holistic representation of the metabolism of an organism at certain time point, metabolomic data contain not only information about current life-style factors like diet and smoking but also about latent genetic traits. Utilizing this integrative attribute, the dissertation delivers a metric for biological age (the metabolic age score) which was shown to be informative beyond chronological age in three independent samples. It was associated with a broad range of age-related comorbidities in two large population-based cohorts, predicted independently of classical risk factors mortality and, moreover, it predicted weight loss subsequently to bariatric surgery in a small sample of heavily obese individuals.
Subsequently to this work, the dissertation built a definitional framework justifying the procedure underlying the metabolic age score, delivering a general framework for the construction of individualized phenotypes and thereby an operationalization of individualization in statistical terms. Conceptualizing individualization of the process of differentiation of individuals showing the same phenotype despite different underlying biological traits, it was shown formally that the prediction error of a statistical model approximating a phenotype is always informative about the underlying biology beyond the phenotype if the predictors fulfill certain statistical requirements. Thus, the prediction error facilitates the meaningful differentiation of individuals showing the same phenotype. The definitional framework presented here is not restricted to any kind of data and is therefore applicable to a broad range of medical research questions.
However, when utilizing metabolomic data, technical factors, data-preprocessing, pre-analytic features introduce unwanted variance into the statistical modeling. Thus, it is unclear whether predictive models like the metabolic age score are stable enough for clinical application. The third part of this doctoral thesis provided two statistical criteria to decide which normalization method to remove the dilution variance from urinary metabolome data performs best in terms of erroneous variance introduced by the different methods, aiding the minimization of biological irrelevant variance in metabolomic analyses.
In conclusion, this doctoral thesis developed a general, applicable, definitional framework for the construction of individualized phenotypes and demonstrated the value of the methodology for clinical phenotypes on metabolomic data, improving on the way the statistical treatment of urinary data regarding the dilution correction.
The early-life microbiome (ELM) interacts with the psychosocial environment, in particular during early-life adversity (ELA), defining life-long health trajectories. The ELM also plays a significant role in the maturation of the immune system. We hypothesised that, in this context, the resilience of the oral microbiomes, despite being composed of diverse and distinct communities, allows them to retain an imprint of the early environment. Using 16S amplicon sequencing on the EpiPath cohort, we demonstrate that ELA leaves an imprint on both the salivary and buccal oral microbiome 24 years after exposure to adversity. Furthermore, the changes in both communities were associated with increased activation, maturation, and senescence of both innate and adaptive immune cells, although the interaction was partly dependent on prior herpesviridae exposure and current smoking. Our data suggest the presence of multiple links between ELA, Immunosenescence, and cytotoxicity that occur through long-term changes in the microbiome.